Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China
Open Access
- 1 February 2021
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 55, 30-36
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Chinese Academy of Medical Sciences
This publication has 23 references indexed in Scilit:
- A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina ExperienceThe Oncologist, 2015
- Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice GuidelineJournal of Clinical Oncology, 2014
- Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 studyThe Lancet Oncology, 2013
- Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogramNeuro-Oncology, 2012
- Incidence of brain metastases as a first site of recurrence among women with triple receptor–negative breast cancerCancer, 2012
- Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from registHERClinical Cancer Research, 2011
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)Annals of Oncology, 2006
- CNS Metastases in Breast CancerJournal of Clinical Oncology, 2004
- Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survivalAnnals of Oncology, 2003